世界のゴーシェ病（GD）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gaucher Disease (GD) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5747
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ゴーシェ病（GD）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、基質減少療法）、用途別市場規模（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ゴーシェ病（GD）治療薬の市場動向
・企業の競争状況、市場シェア
・ゴーシェ病（GD）治療薬の種類別市場規模と予測2016-2027（酵素補充療法、基質減少療法）
・ゴーシェ病（GD）治療薬の用途別市場規模と予測2016-2027（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）
・ゴーシェ病（GD）治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・ゴーシェ病（GD）治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ゴーシェ病（GD）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ゴーシェ病（GD）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・ゴーシェ病（GD）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Shire、Actelion Pharma、Pfizer (Protalix)、ISU ABXIS）
・結論

Gaucher disease is an inherited disorder that affects many of the body’s organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.

Market Analysis and Insights: Global Gaucher Disease (GD) Drugs Market
The global Gaucher Disease (GD) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gaucher Disease (GD) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gaucher Disease (GD) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gaucher Disease (GD) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gaucher Disease (GD) Drugs market.

Global Gaucher Disease (GD) Drugs Scope and Market Size
Gaucher Disease (GD) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease (GD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy

Segment by Application
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Shire
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gaucher Disease (GD) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.3 Market by Application
1.3.1 Global Gaucher Disease (GD) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Non-neuronopathic Gaucher Disease
1.3.3 Neuronopathic Gaucher Disease
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gaucher Disease (GD) Drugs Market Perspective (2016-2027)
2.2 Gaucher Disease (GD) Drugs Growth Trends by Regions
2.2.1 Gaucher Disease (GD) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gaucher Disease (GD) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Gaucher Disease (GD) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Gaucher Disease (GD) Drugs Industry Dynamic
2.3.1 Gaucher Disease (GD) Drugs Market Trends
2.3.2 Gaucher Disease (GD) Drugs Market Drivers
2.3.3 Gaucher Disease (GD) Drugs Market Challenges
2.3.4 Gaucher Disease (GD) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gaucher Disease (GD) Drugs Players by Revenue
3.1.1 Global Top Gaucher Disease (GD) Drugs Players by Revenue (2016-2021)
3.1.2 Global Gaucher Disease (GD) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Gaucher Disease (GD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gaucher Disease (GD) Drugs Revenue
3.4 Global Gaucher Disease (GD) Drugs Market Concentration Ratio
3.4.1 Global Gaucher Disease (GD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gaucher Disease (GD) Drugs Revenue in 2020
3.5 Gaucher Disease (GD) Drugs Key Players Head office and Area Served
3.6 Key Players Gaucher Disease (GD) Drugs Product Solution and Service
3.7 Date of Enter into Gaucher Disease (GD) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gaucher Disease (GD) Drugs Breakdown Data by Type
4.1 Global Gaucher Disease (GD) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Gaucher Disease (GD) Drugs Forecasted Market Size by Type (2022-2027)

5 Gaucher Disease (GD) Drugs Breakdown Data by Application
5.1 Global Gaucher Disease (GD) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Gaucher Disease (GD) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gaucher Disease (GD) Drugs Market Size (2016-2027)
6.2 North America Gaucher Disease (GD) Drugs Market Size by Type
6.2.1 North America Gaucher Disease (GD) Drugs Market Size by Type (2016-2021)
6.2.2 North America Gaucher Disease (GD) Drugs Market Size by Type (2022-2027)
6.2.3 North America Gaucher Disease (GD) Drugs Market Size by Type (2016-2027)
6.3 North America Gaucher Disease (GD) Drugs Market Size by Application
6.3.1 North America Gaucher Disease (GD) Drugs Market Size by Application (2016-2021)
6.3.2 North America Gaucher Disease (GD) Drugs Market Size by Application (2022-2027)
6.3.3 North America Gaucher Disease (GD) Drugs Market Size by Application (2016-2027)
6.4 North America Gaucher Disease (GD) Drugs Market Size by Country
6.4.1 North America Gaucher Disease (GD) Drugs Market Size by Country (2016-2021)
6.4.2 North America Gaucher Disease (GD) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gaucher Disease (GD) Drugs Market Size (2016-2027)
7.2 Europe Gaucher Disease (GD) Drugs Market Size by Type
7.2.1 Europe Gaucher Disease (GD) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Gaucher Disease (GD) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Gaucher Disease (GD) Drugs Market Size by Type (2016-2027)
7.3 Europe Gaucher Disease (GD) Drugs Market Size by Application
7.3.1 Europe Gaucher Disease (GD) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Gaucher Disease (GD) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Gaucher Disease (GD) Drugs Market Size by Application (2016-2027)
7.4 Europe Gaucher Disease (GD) Drugs Market Size by Country
7.4.1 Europe Gaucher Disease (GD) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Gaucher Disease (GD) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gaucher Disease (GD) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type
8.2.1 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application
8.3.1 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region
8.4.1 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gaucher Disease (GD) Drugs Market Size (2016-2027)
9.2 Latin America Gaucher Disease (GD) Drugs Market Size by Type
9.2.1 Latin America Gaucher Disease (GD) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Gaucher Disease (GD) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Gaucher Disease (GD) Drugs Market Size by Type (2016-2027)
9.3 Latin America Gaucher Disease (GD) Drugs Market Size by Application
9.3.1 Latin America Gaucher Disease (GD) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Gaucher Disease (GD) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Gaucher Disease (GD) Drugs Market Size by Application (2016-2027)
9.4 Latin America Gaucher Disease (GD) Drugs Market Size by Country
9.4.1 Latin America Gaucher Disease (GD) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Gaucher Disease (GD) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gaucher Disease (GD) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type
10.2.1 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application
10.3.1 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country
10.4.1 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Gaucher Disease (GD) Drugs Introduction
11.1.4 Sanofi Revenue in Gaucher Disease (GD) Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Shire Business Overview
11.2.3 Shire Gaucher Disease (GD) Drugs Introduction
11.2.4 Shire Revenue in Gaucher Disease (GD) Drugs Business (2016-2021)
11.2.5 Shire Recent Development
11.3 Actelion Pharma
11.3.1 Actelion Pharma Company Details
11.3.2 Actelion Pharma Business Overview
11.3.3 Actelion Pharma Gaucher Disease (GD) Drugs Introduction
11.3.4 Actelion Pharma Revenue in Gaucher Disease (GD) Drugs Business (2016-2021)
11.3.5 Actelion Pharma Recent Development
11.4 Pfizer (Protalix)
11.4.1 Pfizer (Protalix) Company Details
11.4.2 Pfizer (Protalix) Business Overview
11.4.3 Pfizer (Protalix) Gaucher Disease (GD) Drugs Introduction
11.4.4 Pfizer (Protalix) Revenue in Gaucher Disease (GD) Drugs Business (2016-2021)
11.4.5 Pfizer (Protalix) Recent Development
11.5 ISU ABXIS
11.5.1 ISU ABXIS Company Details
11.5.2 ISU ABXIS Business Overview
11.5.3 ISU ABXIS Gaucher Disease (GD) Drugs Introduction
11.5.4 ISU ABXIS Revenue in Gaucher Disease (GD) Drugs Business (2016-2021)
11.5.5 ISU ABXIS Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gaucher Disease (GD) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Substrate Reduction Therapy
Table 4. Global Gaucher Disease (GD) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gaucher Disease (GD) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gaucher Disease (GD) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gaucher Disease (GD) Drugs Market Share by Regions (2016-2021)
Table 8. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gaucher Disease (GD) Drugs Market Share by Regions (2022-2027)
Table 10. Gaucher Disease (GD) Drugs Market Trends
Table 11. Gaucher Disease (GD) Drugs Market Drivers
Table 12. Gaucher Disease (GD) Drugs Market Challenges
Table 13. Gaucher Disease (GD) Drugs Market Restraints
Table 14. Global Gaucher Disease (GD) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gaucher Disease (GD) Drugs Market Share by Players (2016-2021)
Table 16. Global Top Gaucher Disease (GD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease (GD) Drugs as of 2020)
Table 17. Ranking of Global Top Gaucher Disease (GD) Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gaucher Disease (GD) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gaucher Disease (GD) Drugs Product Solution and Service
Table 21. Date of Enter into Gaucher Disease (GD) Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gaucher Disease (GD) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gaucher Disease (GD) Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gaucher Disease (GD) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gaucher Disease (GD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gaucher Disease (GD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gaucher Disease (GD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gaucher Disease (GD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gaucher Disease (GD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gaucher Disease (GD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gaucher Disease (GD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gaucher Disease (GD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gaucher Disease (GD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gaucher Disease (GD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gaucher Disease (GD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gaucher Disease (GD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gaucher Disease (GD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gaucher Disease (GD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gaucher Disease (GD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Gaucher Disease (GD) Drugs Product
Table 64. Sanofi Revenue in Gaucher Disease (GD) Drugs Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Shire Company Details
Table 67. Shire Business Overview
Table 68. Shire Gaucher Disease (GD) Drugs Product
Table 69. Shire Revenue in Gaucher Disease (GD) Drugs Business (2016-2021) & (US$ Million)
Table 70. Shire Recent Development
Table 71. Actelion Pharma Company Details
Table 72. Actelion Pharma Business Overview
Table 73. Actelion Pharma Gaucher Disease (GD) Drugs Product
Table 74. Actelion Pharma Revenue in Gaucher Disease (GD) Drugs Business (2016-2021) & (US$ Million)
Table 75. Actelion Pharma Recent Development
Table 76. Pfizer (Protalix) Company Details
Table 77. Pfizer (Protalix) Business Overview
Table 78. Pfizer (Protalix) Gaucher Disease (GD) Drugs Product
Table 79. Pfizer (Protalix) Revenue in Gaucher Disease (GD) Drugs Business (2016-2021) & (US$ Million)
Table 80. Pfizer (Protalix) Recent Development
Table 81. ISU ABXIS Company Details
Table 82. ISU ABXIS Business Overview
Table 83. ISU ABXIS Gaucher Disease (GD) Drugs Product
Table 84. ISU ABXIS Revenue in Gaucher Disease (GD) Drugs Business (2016-2021) & (US$ Million)
Table 85. ISU ABXIS Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gaucher Disease (GD) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Substrate Reduction Therapy Features
Figure 4. Global Gaucher Disease (GD) Drugs Market Share by Application: 2020 VS 2027
Figure 5. Non-neuronopathic Gaucher Disease Case Studies
Figure 6. Neuronopathic Gaucher Disease Case Studies
Figure 7. Gaucher Disease (GD) Drugs Report Years Considered
Figure 8. Global Gaucher Disease (GD) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Gaucher Disease (GD) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Gaucher Disease (GD) Drugs Market Share by Regions: 2020 VS 2027
Figure 11. Global Gaucher Disease (GD) Drugs Market Share by Regions (2022-2027)
Figure 12. Global Gaucher Disease (GD) Drugs Market Share by Players in 2020
Figure 13. Global Top Gaucher Disease (GD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease (GD) Drugs as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Gaucher Disease (GD) Drugs Revenue in 2020
Figure 15. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2022-2027)
Figure 17. North America Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Gaucher Disease (GD) Drugs Market Share by Type (2016-2027)
Figure 19. North America Gaucher Disease (GD) Drugs Market Share by Application (2016-2027)
Figure 20. North America Gaucher Disease (GD) Drugs Market Share by Country (2016-2027)
Figure 21. United States Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gaucher Disease (GD) Drugs Market Share by Type (2016-2027)
Figure 25. Europe Gaucher Disease (GD) Drugs Market Share by Application (2016-2027)
Figure 26. Europe Gaucher Disease (GD) Drugs Market Share by Country (2016-2027)
Figure 27. Germany Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gaucher Disease (GD) Drugs Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Gaucher Disease (GD) Drugs Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Gaucher Disease (GD) Drugs Market Share by Region (2016-2027)
Figure 37. China Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gaucher Disease (GD) Drugs Market Share by Type (2016-2027)
Figure 45. Latin America Gaucher Disease (GD) Drugs Market Share by Application (2016-2027)
Figure 46. Latin America Gaucher Disease (GD) Drugs Market Share by Country (2016-2027)
Figure 47. Mexico Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gaucher Disease (GD) Drugs Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Gaucher Disease (GD) Drugs Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Gaucher Disease (GD) Drugs Market Share by Country (2016-2027)
Figure 53. Turkey Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Gaucher Disease (GD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2016-2021)
Figure 57. Shire Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2016-2021)
Figure 58. Actelion Pharma Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2016-2021)
Figure 59. Pfizer (Protalix) Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2016-2021)
Figure 60. ISU ABXIS Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Status and Forecast 2021-2027
QFJ1-4244 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法（ERT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ポンペ病）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のゴーシェ病＆ポンペ病酵素補充療法市場規模・現状・予測（2021年-2027年）

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5746 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6032 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年）

Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5819 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓癌＆腎細胞癌（RCC）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アフィニトール（エベロリムス）、アバスチン（ベバシズマブ）、カボメティ（カボザンチニブ）、インリタ（アキシチニブ）、ネク...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5800 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗寄生虫剤、抗真菌剤、その他）、用途別市場規模（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他）、主要地...

世界のウィルソン病治療薬市場規模・現状・予測（2021年-2027年）

Global Wilson's Disease Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6072 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ウィルソン病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肝臓、神経精神科、眼科、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Acquired Cystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3750 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、後天性嚢胞性腎疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、その他）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ...

世界のゴーシェ病＆ポンペ病酵素補充療法（ERT）市場規模・現状・予測（2021年-2027年） A type of resistance measuring device which measure the grounding resistance of various devices and the conductor resistance of low resistance. Market Analysis and Insights: Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market The global Gaucher and Pompe Diseases Enzyme Replace…
世界のゴーシェ病＆ポンペ病酵素補充療法市場規模・現状・予測（2021年-2027年） Enzyme replacement therapy (ERT) involves intravenous (IV) infusions to correct the underlying enzyme deficiency that causes symptoms of Gaucher disease Market Analysis and Insights: Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market The global Gaucher and Pompe Diseases Enzyme Repl…
酵素補充療法のグローバル市場2021 Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme. The classification of enzyme replacement therapy includes injectable…
世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
世界の感染症治療薬市場規模・現状・予測（2021年-2027年） Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission. The epidemic of infectious diseases has risen, spending has increased to increase the penetration of treatments for these diseases, initiatives to increase treatment awareness and awarenes…